‘We expect further fine tuning of the existing schemes and policies’
Suresh Pareek, Managing Director, Ideal Cures
The implementation of various schemes and policies by the NDA government has…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Cover Story
‘Hoping that the future of Indian Pharma is brighter than before’
Dr Ajit Dangi, President & CEO, Danssen Consulting
While most reforms carried out by the Modi Government in the past four…
‘I expect more bold initiatives on macro-economic front’
Dr Gopakumar G Nair, CEO, Gopakumar Nair Associates
The Modi Government has been following a policy of concentrating on macro…
‘Funding for pharma companies might be a way to move forward’
Dr Dinesh Dua, Chairman,Pharmexcil, Chairman, Entrepreneurship & Start Ups, CII North India,CEO & Director, Nectar…
‘There is a definite need to support SME upgradation’
Harish Jain, Secretary and Sunil Attavar, President, Karnataka Drugs & Pharmaceuticals Manufacturer’s Association
There is no…
‘We expect the new govt to reduce regulatory intervention’
BR Sikri, Chairman, Fope
First let me highlight the good things done by the present government.:
Recently agreed to publish SQ…
A report card and a wishlist
Demonetisation, Swachh Bharat Abhiyan, Make in India, Digital India, Ayushmaan Bharat and implementation of GST have been the…
Price cap on onco drugs: Will it have the desired impact?
NPPA’s recent move to cap the price of 42 non-scheduled cancer drugs has evoked mixed reactions from the industry. While some…
Honesty is still the best policy!
Amit Rajan, Managing Director, Prosfora Technologies, says that instilling a culture of compliance in a pharma set up is about…
How to build a quality culture to meet GMP compliance?
In order to maintain a quality culture, Rajashri Survase-Ojha, Founder and MD, RAAJ GPRAC advises that organisations must maintain…
Upgrading knowledge and skills in cost-effective manner
Rahul Guha, Partner and Director and India Lead, Healthcare Practice, BCG, gives an insight on identifying possible areas of…
Quality: From compliance to culture
As custodians to ensure patient safety, quality teams in pharma firms must have a mechanism not only to comply but to consistently…
Building a culture of compliance
Lingering cGMP issues underline the importance of hiring right, rigorous training and continuous oversight to consistently comply…
Keynote address: Transforming pharma with disruptive technologies
Shaunak Dave, CEO, Optel Asia gave a rousing key note address on the first day of Pharma CXO Summit 2019 which centred on the…
Inaugural ceremony
Following the successful first edition of the Pharma CXO Summit, The Indian Express (P) Ltd and Express Pharma, in association…
Pharma CXO Summit 2019
Leaders and experts come together to transform India Pharma Inc into a more value-driven industry with the help of disruptive…
Express Pharma Excellence Awards honour export leaders of India Pharma Inc
This year's winners were chosen on the basis of exports turnover and exports growth rate
Enhancing patient engagement with technology
The dawn of the digital era has enabled pharma companies to bring a paradigm shift in its interactions with doctors and patients.…
Patient safety with technology
Bejon Misra, International Consumer Policy Experts and Founder, Safe Medicines India was the last speaker of Day 2. He gave a talk…